METHODS OF TREATING A TUMOR USING AN ANTI-PD-1 ANTIBODY

This disclosure provides a method for treating a subject afflicted with tumor, which method comprises administering to the subject an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity. In some embodiments, the tu...

Full description

Saved in:
Bibliographic Details
Main Authors GEESE WILLIAM J, EDWARDS ROBIN, GREENAWALT DANIELLE M
Format Patent
LanguageChinese
English
Published 10.01.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This disclosure provides a method for treating a subject afflicted with tumor, which method comprises administering to the subject an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity. In some embodiments, the tumor is derived from a non-small cell lung cancer (NSCLC). In some embodiments, the tumor expresses Programmed Death Ligand 1. In some embodiments, the subject carries a wild-type STK11 gene. 本公开提供用于治疗患有肿瘤的受试者的方法,该方法包括对受试者施用特异性结合程序性死亡-1(PD-1)受体并抑制PD-1活性的抗体或其抗原结合部分。在一些实施方案中,该肿瘤源自非小细胞肺癌(NSCLC)。在一些实施方案中,该肿瘤表达程序性死亡配体1。在一些实施方案中,该受试者携带野生型STK11基因。
Bibliography:Application Number: CN20188035434